Article Details

Travere Therapeutics Announces Successful Outcome from Type A Meeting with U.S. FDA for ...

Retrieved on: 2021-09-07 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Travere Therapeutics Announces Successful Outcome from Type A Meeting with U.S. FDA for .... View article details on hiswai:

Excerpt

At the time of the eGFR data cut, all patients remaining in the DUPLEX Study ... is continuing as planned with no changes to the statistical analysis plan, ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up